View the full Blood Cancer OncTalk
This webinar has now ended
The full event video is available OnDemand
Thank you for joining us for GRACE's first Blood Cancer ONCTalk
2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다. 2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포...
For the 2025 Case Based Panel Discussions, a panel of oncologists consisting of Dr. Isabel Preeshagul, Dr. Deborah Doroshow and Dr. Christine Garcia...
The 2025 Targeted Therapies in Lung Cancer Patient Forum was a live, virtual, interactive patient education event presented in March 2025 and led by...
The panel discusses the current standard of care for patients with head and neck cancer who need surgery, the findings of the Keynote 689 study, which...
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente...
As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26...
Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...
Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias...
Thank you for joining us for GRACE's first Blood Cancer ONCTalk
Gallbladder Cancer is a rare disease in which malignant cells form in the tissues of the gallbladder. Bile duct cancer or cholangiocarcinoma is a rare disease in which malignant cells form in the bile ducts. Help us to bring awareness to these rare cancers during the month of February. Start talking and raise awareness to Gallbladder and Bile Duct Cancer Awareness
2025 동아시아 폐암 이미지 라이브러리의 일환으로 서정민 박사(분당서울대학교병원)가 절제 가능한 비소세포 폐암의 수술 주변 관리에 대해 논의합니다.
2025 동아시아 폐암 영상 라이브러리의 일환으로, 김진용 박사(삼성메디컬센터)는 EGFR 돌연변이가 있는 비소세포 폐암 환자를 위한 표적 치료에 대해 논의합니다.
As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
June is National Cancer Survivors Month. As with many terms used in cancer, not everyone who has incurable cancer sees themselves as a survivor if they aren't going to survive cancer, and some people are happy to take on the mantle of "survivor", no matter the prognosis.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock